All In MedTech

Device Trial Radar · NCT07707388

Effect of Theravex Tissue Care on Implant Stability

Effect of Theravex Tissue Care on Implant Stability in Immediate Implant Placement: A Randomized Controlled Clinical Trial

Last checked: Nov 19, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Nov 12, 2026

Primary completion

Jun 30, 2027

Study completion Sep 8, 2027

Sponsor

Lead sponsor
Ain Shams UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this randomized clinical trial is to evaluate the clinical and radiographic outcomes of using Bone Bioactive Liquid (Theravex) compared to Xenograft and a combination therapy (Theravex + Xenograft) during immediate implant placement in the esthetic zone. When a tooth is extracted and replaced immediately with a dental implant, bone grafting is often necessary to fill the gap (jumping distance) between the implant and the surrounding bone socket to support tissue healing and maintain facial contour. Participants requiring immediate implant placement will be randomly assigned into three groups: Group 1: Immediate implant placement using Bone Bioactive Liquid (Theravex). Group 2: Immediate implant placement using Xenograft alone. Group 3: Immediate implant placement using Combination Therapy (Theravex + Xenograft). The primary outcomes will evaluate implant stability, bone dimensional changes, and soft tissue response around the implants over the follow-up period.

Conditions

  • Immediate Dental Implant Placement

Interventions

  • Bone Bioactive LiquidDevice

    A bone bioactive liquid (Theravex) applied directly into the jumping gap and on implant surface immediately following implant placement to stimulate early bone healing and osseointegration.

  • Bovine-derived XenograftDevice

    Bovine derived- xenograft will be packed into the jumping gap to maintain volume and provide an osteoconductive scaffold for bone formation.

  • Immediate Implant PlacementProcedure

    Surgical placement of the dental implant into the fresh extraction socket immediately following tooth extraction, according to standard surgical protocols.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Implant Stability Quotient (ISQ)Time frame: Baseline (during surgery), 4 weeks, 3 months, and 6 months post-operatively.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Faculty of Dentistry - Ain Shams University

    Cairo, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.